The enhanced green fluorescent protein (eGFP) is minimally immunogenic in C57BL/6 mice [1]

Gene Therapy

Volumn 8, Issue 23, 2001, Pages 1813-1814

  Skelton, D ^a   Satake, N ^a   Kohn, D B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BLOOD CLOTTING FACTOR 9; GREEN FLUORESCENT PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE THERAPY; GENE TRANSFER; IMMUNOGENICITY; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; STRAIN DIFFERENCE;

ANIMALS; GREEN FLUORESCENT PROTEINS; IMMUNE TOLERANCE; LEUKEMIA, EXPERIMENTAL; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPECIES SPECIFICITY; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA;

EID: 0035704168     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301586     Document Type: Letter

References (7)

1. T cell-mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients
2. Immune response to green fluorescent protein: Implications for gene therapy
3. Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells
4. Adenovirus-mediated gene transfer: Influence of transgene, mouse strain and type of immune response on persistence of transgene expression
5. Strain-related variations in adenovirally-mediated transgene expression from mouse hepatocytes in vivo comparisons between immunocompetent and immunodeficient strains
6. Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice
7. EGFP-transduced EL-4 cells form tumors in C57BL/6 mice